Boomerang Ventures
Josh Nickols, PhD


Venture Partner

Josh Nickols, Ph.D., is a Venture Partner at Boomerang Ventures and Chief Executive Officer at AgriThera Inc., an Atlanta-based pharmaceutical start-up focusing on bringing new cannabinoid therapeutics for the treatment of seizure disorders, anxiety, and chronic pain to market.

Josh also advises the development of assets from the portfolio at the University of Louisville. Previously, he was CEO at GlobalCastMD, an Ohio-based company that offers services that enables healthcare professionals and institutions the ability to shape their knowledge into engaging and more widely accessed content. He also was CEO of XII Medical, a private health technology company developing a neuromodulation solution for the treatment of obstructive sleep apnea.

He previously served as a committee member at NIH Center for Accelerated Innovations (NCAI), headquartered at Cleveland Clinic, and as Executive in Residence at CincyTech USA, a public-private seed-stage investor that helps transform ideas into high-potential life science and digital companies in southwest Ohio.

Josh earned a bachelor’s degree in Biology at Washington University in St. Louis, a doctorate in molecular neuroscience at Vanderbilt University School of Medicine, and an MBA in finance and marketing at Vanderbilt’s Owen Graduate School of Management.

Boomerang Ventures